Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 2Phase 1 1

Status

Terminated 2Active not recruiting 2Withdrawn 1Unknown 1Completed 1

Sponsor Class

INDUSTRY 3OTHER_GOV 2OTHER 2

Study Type

Interventional 7Observational 3

Sponsor

Cancer Type

Other 7

Conditions

Obesity 298Mucositis 116Neoplasms 108Breast Neoplasms 87Overweight 80Sexual Dysfunction, Physiological 74Polycystic Ovary Syndrome 71Dyspnea 48Motor Activity 46Constipation 45Head and Neck Neoplasms 42Weight Loss 36Prostatic Neoplasms 32Pain 29Stomatitis 26Endometrial Neoplasms 23Opioid-Induced Constipation 21Multiple Endocrine Neoplasia Type 1 20Diabetes Mellitus 20Lung Neoplasms 18Colorectal Neoplasms 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Sexual Dysfunctions, Psychological 15Depression 15Cardiovascular Diseases 15Anxiety Disorders 15Sedentary Behavior 13Insulin Resistance 13Infertility 13Cancer-related Fatigue 13

Interventions

poly(methyl methacrylate)-b-polycaprolactone-N-acetylcysteine 1ART123 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × Chemotherapy-induced Peripheral Neuropathy × Other × Clear all
NCT05771974 2026-02-27

AIUR

Incheon St.Mary's Hospital

Phase NA Active not recruiting
104 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT05371158 2025-08-15

QLIPP-CIPN

Tilburg University

Phase NA Terminated
112 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT05251727 2024-08-19

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

Veloxis Pharmaceuticals

Phase 1 Terminated
77 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT05593614 2024-07-16

ACT

AlgoTherapeutix

Phase 2 Active not recruiting
276 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT06132776 2024-04-26

The Mamma HiToP Study

Vienna Hospital Association

Phase NA Unknown
160 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT05539053 2024-01-25

Efficacy of NAC for the Prevention and Relief of PIPN in Women With Ovarian, Tubal, and Peritoneal Cancer

Department of Medical Services Ministry of Public Health of Thailand

Phase NA Completed
60 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT04282590 2022-03-15

A Study to Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)

Toray Industries, Inc

Phase 2 Withdrawn
Other

Chemotherapy-induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡